A new ligand extends the half-life of peptide drugs from minutes to days

EPFL scientists have developed a ligand molecule that connects peptide drugs to blood-serum albumin and keeps them from being cleared out by the kidneys too soon. The ligand is easy to synthesize and can extend the half-life of therapeutic peptides from minutes to several days.

Top News

Ain't No God; don't even think about theism

UnFox News: not a propaganda arm of the Republican party